Venous Thromboembolism and Gender-Affirming Hormone Therapy: A Reappraisal of Risks and Benefits.
Koen M A Dreijerink
Author Information
- Koen M A Dreijerink: Amsterdam UMC, location VU University Medical Center; Department of Endocrinology and Metabolism; Research Institute Amsterdam Gastroenterology, Endocrinology, and Metabolism; Center of Expertise on Gender Dysphoria, Amsterdam, the Netherlands. Electronic address: k.dreijerink@amsterdamumc.nl.
No abstract text available.
Humans
Venous Thromboembolism
Gender Identity
Risk Factors
Hormones
Risk Assessment
Transgender Persons
